Gilead Sciences
Fabrizio Rudari is a trainee at Gilead Sciences since October 2023, bringing prior experience as a Junior Project Manager and Data Analyst at Eurofins Genomics from November 2020 to October 2023. Fabrizio has also contributed to research at King’s College London as a King’s Undergraduate Research Fellowship member in July 2019, focusing on mutations in CHD8 related to autism and other neurodevelopmental disorders, and as a Research Assistant in June and July 2018, investigating chromatin remodeling factors in brain development. An internship at the European Patent Office in June 2012 involved shadowing a patent examiner and attending oral proceedings. Educational qualifications include an MRes in Drug Sciences from UCL, a BS in Pharmacology and Molecular Genetics from King’s College London, and a Bachelor of Arts in European Studies from King’s College London with a year abroad, alongside the Baccalauréat Européen from Europäische Schule München.
This person is not in any teams
This person is not in any offices
Gilead Sciences
159 followers
Gilead Sciences is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for critical diseases.